[HTML][HTML] Modern Management of Cardiometabolic Continuum: From Overweight/Obesity to Prediabetes/Type 2 Diabetes Mellitus. Recommendations from the Eastern …
The increasing global incidence of obesity and type 2 diabetes mellitus (T2D) underscores
the urgency of addressing these interconnected health challenges. Obesity enhances …
the urgency of addressing these interconnected health challenges. Obesity enhances …
[HTML][HTML] Therapeutic Potential of Various Intermittent Fasting Regimens in Alleviating Type 2 Diabetes Mellitus and Prediabetes: A Narrative Review
S Msane, A Khathi, A Sosibo - Nutrients, 2024 - mdpi.com
Intermittent fasting has drawn significant interest in the clinical research community due to its
potential to address metabolic complications such as obesity and type 2 diabetes mellitus …
potential to address metabolic complications such as obesity and type 2 diabetes mellitus …
SGLT2i and GLP1RA effects in patients followed in a hospital diabetology consultation
AC Lopes, O Lourenço, M Morgado - Expert Review of Clinical …, 2024 - Taylor & Francis
Background We aimed to investigate the effects of sodium-glucose cotransporter 2 inhibitors
(SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP1RA) in patients with type 2 …
(SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP1RA) in patients with type 2 …
[HTML][HTML] Lipid-Lowering Therapy after Acute Coronary Syndrome
E Pogran, AL Burger, D Zweiker, CC Kaufmann… - Journal of Clinical …, 2024 - mdpi.com
Achieving guideline-recommended low-density lipoprotein cholesterol (LDL-C) targets
remains a significant challenge in clinical practice. This review assesses the barriers to …
remains a significant challenge in clinical practice. This review assesses the barriers to …
Real-World Utilization and Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists Dosed Weekly and Daily in Patients with Type 2 Diabetes Mellitus: Results …
Z Ruan, X Chen, M Song, R Jia, H Luo… - Diabetes, Metabolic …, 2024 - Taylor & Francis
Aim This study aimed to conduct a retrospective observational study in China to investigate
the real-world utilization of glucagon-like peptide-1 receptor (GLP-1RA) in China. Methods …
the real-world utilization of glucagon-like peptide-1 receptor (GLP-1RA) in China. Methods …
[HTML][HTML] Transforming Diabetes Care: The Molecular Pathways through Which GLP1-RAs Impact the Kidneys in Diabetic Kidney Disease
M Rroji, G Spasovski - Biomedicines, 2024 - mdpi.com
Diabetic kidney disease (DKD) is a substantial complication of type 2 diabetes (T2D),
presenting challenges in chronic kidney disease (CKD) management. In addition to …
presenting challenges in chronic kidney disease (CKD) management. In addition to …
[HTML][HTML] The Effect of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists on the Lipid Profile of Diabetic Patients Using Statins: A Retrospective Cohort Study in the …
OM Albahli, S Ali, F Alblaihi, AA Aljaman - Cureus, 2024 - pmc.ncbi.nlm.nih.gov
Background Dyslipidemia is a common complication of type 2 diabetes mellitus (T2DM),
which is the leading cause of morbidity and mortality in developed countries, including …
which is the leading cause of morbidity and mortality in developed countries, including …
[PDF][PDF] Awareness of Population Regarding GLP-1 (liraglutide and Semaglutide) Prescribing in PHCC in Abha City, KSA
MA Humeyed, MAAL Mater, SM Alshehri… - MIDDLE EAST JOURNAL … - mejfm.com
Background: GLP-1 is a peptide hormone related to the glucagon superfamily and shares a
significant amino acid sequence with glucagon. The glucagon superfamily peptides are …
significant amino acid sequence with glucagon. The glucagon superfamily peptides are …